The Society of Cardiovascular Angiography and Interventions has published an expert consensus statement on the management of patients with ST-elevation myocardial infarction. Experts agree reperfusion ...
Medical Management/Treatment Initial treatment for suspected STEMI and NSTEMI requires a loading dose of nonenteric coated ASA at 162 to 325 mg (unless contraindicated), nitroglycerin in response to ...
The Society for Cardiovascular Angiography & Interventions (SCAI) is pleased to announce the publication of the Expert Consensus Statement on the Management of Patients with STEMI Referred for Primary ...
Background Despite advances in acute coronary syndrome (ACS) management, contemporary data assessing long-term prognosis ...
The Society for Cardiovascular Angiography & Interventions (SCAI) is pleased to announce the publication of the Expert Consensus Statement on the Management of Patients with STEMI Referred for Primary ...
In a new publication from Cardiovascular Innovations and Applications, Sameh Shaheen, Ayman Helal, and Islam Anan from Ain Shams University, Cairo, Egypt, Fayoum University, Fayoum, Egypt, and Queen ...
For the management of ST-segment elevation acute myocardial infarction (STEMI), international guidelines recommend primary percutaneous coronary intervention with adjunctive antithrombotic therapy, ...
A computerized system that can diagnose ST-elevation myocardial infarction (STEMI) using field electrocardiograms (ECGs) without the need for physician input nearly eliminates treatment delays, ...
The risk of dying over the next decade for STEMI patients who survive the first 90 days after primary PCI is just a few percentage points higher than people in the general population, an observational ...
Late-onset atrial fibrillation affects survival and risk for major adverse cardiovascular events in patients with myocardial infarction.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results